25 XP   0   0   10

Essex Bio-Technology Ltd
Buy, Hold or Sell?

Let's analyse Essex Bio-Technology Ltd together

PenkeI guess you are interested in Essex Bio-Technology Ltd. Buy, hold or sell? I don't know! However, I do recommend doing research before doing anything. I will help you with that.

I'm going to help you getting a better view of Essex Bio-Technology Ltd. At the end you don't have to ask anyone for trading advice. You can make your own decision, with more confidence, the odds in your favor, backed by data.

You can find me behind Let's Analyse Together in the top-right of each section.

Get notifications about Essex Bio-Technology Ltd

I send you an email if I find something interesting about Essex Bio-Technology Ltd.

Quick analysis of Essex Bio-Technology Ltd (30 sec.)










What can you expect buying and holding a share of Essex Bio-Technology Ltd? (30 sec.)

How much money do you get?

How much money do you get?
HK$0.01
When do you have the money?
1 year
How often do you get paid?
96.6%

What is your share worth?

Current worth
HK$3.17
Expected worth in 1 year
HK$3.30
How sure are you?
93.1%

+ What do you gain per year?

Total Gains per Share
HK$0.20
Return On Investment
7.6%

For what price can you sell your share?

Current Price per Share
HK$2.60
Expected price per share
HK$2.14 - HK$2.69
How sure are you?
50%

1. Valuation of Essex Bio-Technology Ltd (5 min.)




Live pricePrice per Share (EOD)

HK$2.60

Intrinsic Value Per Share

HK$9.20 - HK$10.85

Total Value Per Share

HK$12.37 - HK$14.02

2. Growth of Essex Bio-Technology Ltd (5 min.)




Is Essex Bio-Technology Ltd growing?

Current yearPrevious yearGrowGrow %
How rich?$231.7m$217.5m$7.2m3.2%

How much money is Essex Bio-Technology Ltd making?

Current yearPrevious yearGrowGrow %
Making money$12.3m$15.5m-$3.2m-26.2%
Net Profit Margin8.0%10.4%--

How much money comes from the company's main activities?

3. Financial Health of Essex Bio-Technology Ltd (5 min.)




What can you expect buying and holding a share of Essex Bio-Technology Ltd? (5 min.)

Welcome investor! Essex Bio-Technology Ltd's management wants to use your money to grow the business. In return you get a share of Essex Bio-Technology Ltd.

What can you expect buying and holding a share of Essex Bio-Technology Ltd?

First you should know what it really means to hold a share of Essex Bio-Technology Ltd. And how you can make/lose money.

Speculation

The Price per Share of Essex Bio-Technology Ltd is HK$2.6. The market price reflects what other people think it is worth; not what it's really worth. Your job is to find out if the market price is fair, overpriced, or underpriced. I will help you with that.

If you buy blind, there is a 50% chance of making or losing money by selling the stock in the future. However, we can look at a few things to determine the odds in our favor:

  • The fundamentals: the financial health trends of Essex Bio-Technology Ltd.
  • The technials: based on market psychology, we can make a calculated estimate of what the price will do in the future. We can do this through technical analysis. We can calculate the probabilities and the expected value (millionaire math). That's called speculation.
  • The book value: what is the market price compared to it's book value.

Investing

If you really want to invest in Essex Bio-Technology Ltd, you will have to let go of the thought of selling in the future. If you have to sell the share for less than you bought it, it can still be a good investment. Focus on what it means to hold the stock forever:

  • You own a part of the company. The equity of this part can grow or shrink. The current Book Value per Share is HK$3.17. Based on the TTM, the Book Value Change Per Share is HK$0.03 per quarter. Based on the YOY, the Book Value Change Per Share is HK$0.08 per quarter.
  • You may receive quarterly/yearly dividend in the form of additional shares.
  • You may receive quarterly/yearly dividend in the form of cash. Based on the TTM the Dividend per Share is HK$0.02 per quarter.
Based on historical numbers we can estimate the returns while holding a share of Essex Bio-Technology Ltd.

How much money are you going to get?

 MRQTTMYOY5Y10Y
 HK$% of Price per ShareHK$% of Price per ShareHK$% of Price per ShareHK$% of Price per ShareHK$% of Price per Share
Usd Eps0.020.7%0.010.6%0.020.7%0.020.7%0.010.6%
Usd Book Value Change Per Share0.020.7%0.000.2%0.010.4%0.010.4%0.010.5%
Usd Dividend Per Share0.000.1%0.000.1%0.000.1%0.000.1%0.000.1%
Usd Total Gains Per Share0.020.8%0.010.2%0.010.5%0.010.5%0.010.6%
Usd Price Per Share0.46-0.48-0.61-0.64-0.59-
Price to Earnings Ratio6.03-9.45-8.45-11.27-12.13-
Price-to-Total Gains Ratio23.57-203.35-135.47-121.05-91.96-
Price to Book Ratio1.13-1.23-1.62-2.20-3.14-
Price-to-Total Gains Ratio23.57-203.35-135.47-121.05-91.96-

When do you get the money?

Usd Investment
$.00
Usd Price Per Share0.33332
Number of shares3000
Gains per QuarterTrailing 12 Months5 Year
Usd Dividend Per Share0.000.00
Usd Book Value Change Per Share0.000.01
Usd Total Gains Per Share0.010.01
Gains per Quarter (3000 shares)19.0642.45
Gains per Year (3000 shares)76.24169.79
YearsReturn on Investment (TTM)Return on Investment (5Y)
 DividendBook Value gainTotal gainsDividendBook Value gainTotal gains
Broker costs---10---10
125516635135160
25010314269270330
375154218104406500
4100205294138541670
5125256370173676840
61503084462088111010
71753595222429461180
820041059827710811350
922546167431112171520
1025051375034613521690

How sure are you?

Based on the past periods, how sure are you to get value out of your investment.

Linear %
 Trailing 12 Months3Y5 Year10 YearALLTIME
  % % % % %
Earnings Per Share4.00.00.0100.0%12.00.00.0100.0%19.00.00.0100.0%29.00.00.0100.0%46.00.01.097.9%
Book Value Change Per Share1.01.02.025.0%5.01.06.041.7%8.02.09.042.1%18.02.09.062.1%34.04.09.072.3%
Dividend per Share4.00.00.0100.0%12.00.00.0100.0%18.00.01.094.7%28.00.01.096.6%38.00.09.080.9%
Total Gains per Share4.00.00.0100.0%12.00.00.0100.0%17.01.01.089.5%27.01.01.093.1%43.03.01.091.5%

Fundamentals of Essex Bio-Technology Ltd

About Essex Bio-Technology Ltd

Essex Bio-Technology Limited, an investment holding company, develops, manufactures, distributes, and sells bio-pharmaceutical products in the People's Republic of China, Hong Kong, and internationally. The company operates through Ophthalmology and Surgical segments. It researches and develops therapeutic fibroblast growth factor products for the treatment of cellular proliferation, differentiation, and migration. The company offers Beifushu series, such as Beifushu eye drops, Beifushu eye gel, and Beifushu unit-dose eye drops; Tobramycin eye drops, Levofloxacin eye drops, and Sodium Hyaluronate eye drops, as well as Iodized Lecithin Capsules. It also provides Beifuji sprays and lyophilized powder, and Beifuxin gels. In addition, the company offers ophthalmic and surgical products from third parties. Further, the company offers Carisolv dental caries removal gel; and mouth wash Granules; and collagen-based artificial dermis. It has license agreements with Mitotech S.A. and Mitotech LLC for clinical trial of ophthalmic solution containing SkQ1 for dry eye disease; and Shanghai Henlius Biotech Inc. to co-develop a pharmaceutical product that contains an anti-vascular endothelial growth factor as a drug substance, which is intended for the treatment of exudative (wet) age-related macular degeneration. The company was founded in 1990 and is headquartered in Zhuhai, China.

Fundamental data was last updated by Penke on 2024-05-10 16:06:05.

Financial Health

Profitability Details
 Compared to previous yearCompared to industry
The company is making a profit.
Using its assets, the company is less efficient in making profit.
Using its investors money, the company is less efficient in making profit.
Operating Efficiency Details
 Compared to previous yearCompared to industry
The company is operating less efficient.
The company is very efficient in keeping operating costs low.
Liquidity Details
 Compared to previous yearCompared to industry
The company is able to pay all its short-term debts.
The company is able to pay all its short-term debts with the most liquid assets.
Solvency Details
 Compared to previous yearCompared to industry
The company is very able to pay all its debts by selling its assets.
The company is very able to pay all its debts with equity.

Valuation

Valuation Details
 Compared to previous yearCompared to industry
Based on the equity, the company is underpriced.
Based on the earnings, the company is underpriced.
Based on how much money comes from the company's main activities, the company is cheap.

1.1. Profitability of Essex Bio-Technology Ltd.

1.1. Profitability
1.1.1. Net Profit Margin

Measures how much net profit Essex Bio-Technology Ltd earns for each $1 of revenue.

  • Above 10% is considered healthy but always compare Essex Bio-Technology Ltd to the Drug Manufacturers - Specialty & Generic industry mean.
  • A Net Profit Margin of 18.9% means that $0.19 for each $1 in revenue is generated as profit.

Let's take a look of the Net Profit Margin trends of Essex Bio-Technology Ltd:

  • The MRQ is 18.9%. The company is making a huge profit. +2
  • The TTM is 8.0%. The company is making a profit. +1
Trends
Current periodCompared to+/- 
MRQ18.9%TTM8.0%+10.9%
TTM8.0%YOY10.4%-2.4%
TTM8.0%5Y10.8%-2.8%
5Y10.8%10Y14.3%-3.5%
1.1.2. Return on Assets

Shows how efficient Essex Bio-Technology Ltd is using its assets to generate profit.

  • Above 5% is considered healthy but always compare Essex Bio-Technology Ltd to the Drug Manufacturers - Specialty & Generic industry mean.
  • 6.0% Return on Assets means that Essex Bio-Technology Ltd generated $0.06 profit for each $1 in assets.

Let's take a look of the Return on Assets trends of Essex Bio-Technology Ltd:

  • The MRQ is 6.0%. Using its assets, the company is efficient in making profit. +1
  • The TTM is 3.5%. Using its assets, the company is less efficient in making profit.
Trends
Current periodCompared to+/- 
MRQ6.0%TTM3.5%+2.5%
TTM3.5%YOY4.3%-0.9%
TTM3.5%5Y4.6%-1.1%
5Y4.6%10Y5.0%-0.4%
1.1.3. Return on Equity

Shows how efficient Essex Bio-Technology Ltd is using its investors money to generate profit.

  • Above 15%-20% is considered healthy but always compare Essex Bio-Technology Ltd to the Drug Manufacturers - Specialty & Generic industry mean.
  • 9.4% Return on Equity means Essex Bio-Technology Ltd generated $0.09 for each $1 the owners (shareholders) invested.

Let's take a look of the Return on Equity trends of Essex Bio-Technology Ltd:

  • The MRQ is 9.4%. Using its investors money, the company is less efficient in making profit.
  • The TTM is 5.4%. Using its investors money, the company is less efficient in making profit.
Trends
Current periodCompared to+/- 
MRQ9.4%TTM5.4%+4.0%
TTM5.4%YOY7.1%-1.7%
TTM5.4%5Y7.5%-2.0%
5Y7.5%10Y8.1%-0.6%

1.2. Operating Efficiency of Essex Bio-Technology Ltd.

1.2. Operating Efficiency
1.2.1. Operating Margin

Measures how efficient Essex Bio-Technology Ltd is operating .

  • Measures how much profit Essex Bio-Technology Ltd makes for each $1 of sales after paying variable costs (production costs, wages, etc) but before taxes.
  • Above 15% is considered healthy but always compare Essex Bio-Technology Ltd to the Drug Manufacturers - Specialty & Generic industry mean.
  • An Operating Margin of 11.6% means the company generated $0.12  for each $1 in revenue (before taxes).

Let's take a look of the Operating Margin trends of Essex Bio-Technology Ltd:

  • The MRQ is 11.6%. The company is operating less efficient.
  • The TTM is 5.5%. The company is operating less efficient.
Trends
Current periodCompared to+/- 
MRQ11.6%TTM5.5%+6.1%
TTM5.5%YOY6.0%-0.5%
TTM5.5%5Y6.4%-1.0%
5Y6.4%10Y6.5%-0.1%
1.2.2. Operating Ratio

Measures how efficient Essex Bio-Technology Ltd is keeping operating costs low.

  • Below 1 is considered healthy (always compare to Drug Manufacturers - Specialty & Generic industry mean).
  • An Operation Ratio of 0.10 means that the operating costs are $0.10 for each $1 in net sales.

Let's take a look of the Operating Ratio trends of Essex Bio-Technology Ltd:

  • The MRQ is 0.099. The company is very efficient in keeping operating costs low. +2
  • The TTM is 0.047. The company is very efficient in keeping operating costs low. +2
Trends
Current periodCompared to+/- 
MRQ0.099TTM0.047+0.052
TTM0.047YOY0.062-0.015
TTM0.0475Y0.138-0.091
5Y0.13810Y0.230-0.092

1.3. Liquidity of Essex Bio-Technology Ltd.

1.3. Liquidity
1.3.1. Current Ratio

Measures if Essex Bio-Technology Ltd is able to pay off Short-term Debt.

  • Above 1.5 is considered healthy (always compare to Drug Manufacturers - Specialty & Generic industry mean).
  • A Current Ratio of 2.14 means the company has $2.14 in assets for each $1 in short-term debts.

Let's take a look of the Current Ratio trends of Essex Bio-Technology Ltd:

  • The MRQ is 2.139. The company is able to pay all its short-term debts. +1
  • The TTM is 2.152. The company is able to pay all its short-term debts. +1
Trends
Current periodCompared to+/- 
MRQ2.139TTM2.152-0.012
TTM2.152YOY2.188-0.036
TTM2.1525Y2.150+0.002
5Y2.15010Y2.075+0.075
1.3.2. Quick Ratio

Measures if Essex Bio-Technology Ltd is able to pay off Short-term Debt but only using the most liquid assets.

  • Above 1 is considered healthy but always compare Essex Bio-Technology Ltd to the Drug Manufacturers - Specialty & Generic industry mean.
  • A Quick Ratio of 1.84 means the company can pay off $1.84 for each $1 in debt (using most liquid assets).

Let's take a look of the Quick Ratio trends of Essex Bio-Technology Ltd:

  • The MRQ is 1.843. The company is very able to pay all its short-term debts with the most liquid assets. +2
  • The TTM is 1.404. The company is able to pay all its short-term debts with the most liquid assets. +1
Trends
Current periodCompared to+/- 
MRQ1.843TTM1.404+0.439
TTM1.404YOY1.475-0.072
TTM1.4045Y1.483-0.079
5Y1.48310Y1.387+0.096

1.4. Solvency of Essex Bio-Technology Ltd.

1.3. Liquidity
1.4.1. Debt to Asset Ratio

Measures how much % of Essex Bio-Technology Ltd assets are financed with debt.

  • Below 1 (100%) is considered healthy but always compare Essex Bio-Technology Ltd to Drug Manufacturers - Specialty & Generic industry mean.
  • A Debt to Asset Ratio of 0.36 means that Essex Bio-Technology Ltd assets are financed with 36.1% credit (debt) and the remaining percentage (100% - 36.1%) is financed by its owners/shareholders. 

Let's take a look of the Debt to Asset Ratio trends of Essex Bio-Technology Ltd:

  • The MRQ is 0.361. The company is very able to pay all its debts by selling its assets. +2
  • The TTM is 0.365. The company is very able to pay all its debts by selling its assets. +2
Trends
Current periodCompared to+/- 
MRQ0.361TTM0.365-0.004
TTM0.365YOY0.391-0.025
TTM0.3655Y0.382-0.017
5Y0.38210Y0.380+0.003
1.4.2. Debt to Equity Ratio

Measures if Essex Bio-Technology Ltd is able to pay off its debts by using shareholders equity.

  • Below 2 is considered healthy but always compare Essex Bio-Technology Ltd to the Drug Manufacturers - Specialty & Generic industry mean.
  • A Debt to Equity ratio of 56.5% means that company has $0.56 debt for each $1 in shareholders equity.

Let's take a look of the Debt to Equity Ratio trends of Essex Bio-Technology Ltd:

  • The MRQ is 0.565. The company is very able to pay all its debts with equity. +2
  • The TTM is 0.575. The company is very able to pay all its debts with equity. +2
Trends
Current periodCompared to+/- 
MRQ0.565TTM0.575-0.011
TTM0.575YOY0.641-0.066
TTM0.5755Y0.622-0.046
5Y0.62210Y0.616+0.006

2. Market Valuation of Essex Bio-Technology Ltd

2.1. Earnings Per Share
2.1. Price to Earnings Ratio

Measures how much money you pay for each share for every $1 in earnings Essex Bio-Technology Ltd generates.

  • Above 15 is considered overpriced but always compare Essex Bio-Technology Ltd to the Drug Manufacturers - Specialty & Generic industry mean.
  • A PE ratio of 6.03 means the investor is paying $6.03 for every $1 in earnings.

Let's take a look of the Price to Earnings Ratio trends of Essex Bio-Technology Ltd:

  • The EOD is 4.368. Based on the earnings, the company is cheap. +2
  • The MRQ is 6.031. Based on the earnings, the company is cheap. +2
  • The TTM is 9.446. Based on the earnings, the company is underpriced. +1
Trends
Current periodCompared to+/- 
EOD4.368MRQ6.031-1.663
MRQ6.031TTM9.446-3.414
TTM9.446YOY8.449+0.996
TTM9.4465Y11.266-1.821
5Y11.26610Y12.126-0.859
2.2. Price To Free Cash Flow Ratio

Let's take a look of the Price To Free Cash Flow Ratio trends of Essex Bio-Technology Ltd:

  • The EOD is 4.948. Based on how much money comes from the company's main activities, the company is cheap. +2
  • The MRQ is 6.832. Based on how much money comes from the company's main activities, the company is cheap. +2
  • The TTM is 8.129. Based on how much money comes from the company's main activities, the company is cheap. +2
Trends
Current periodCompared to+/- 
EOD4.948MRQ6.832-1.884
MRQ6.832TTM8.129-1.298
TTM8.129YOY8.803-0.674
TTM8.1295Y19.790-11.661
5Y19.79010Y28.338-8.547
2. Book Value per Share
2.3. Price to Book Ratio

Measures if the stock price of Essex Bio-Technology Ltd is to cheap or to expensive compared to its book value.

Let's take a look of the Price to Book Ratio trends of Essex Bio-Technology Ltd:

  • The EOD is 0.821. Based on the equity, the company is cheap. +2
  • The MRQ is 1.133. Based on the equity, the company is underpriced. +1
  • The TTM is 1.228. Based on the equity, the company is underpriced. +1
Trends
Current periodCompared to+/- 
EOD0.821MRQ1.133-0.312
MRQ1.133TTM1.228-0.095
TTM1.228YOY1.618-0.391
TTM1.2285Y2.199-0.971
5Y2.19910Y3.140-0.941
2. Total Gains per Share

3. Summary

3.1. Key Performance Indicators

The key performance indicators of Essex Bio-Technology Ltd compared to the Most Recent Quarter (MRQ).

 End of day+/-Most Recent QuarterTrailing 12 Months+/-Year-Over-Year+/-5 Year+/-10 Year+/-
Book Value Change Per Share--0.1400.033+320%0.075+86%0.088+59%0.096+46%
Book Value Per Share--3.1693.066+3%2.950+7%2.453+29%1.903+67%
Current Ratio--2.1392.152-1%2.188-2%2.1500%2.075+3%
Debt To Asset Ratio--0.3610.365-1%0.391-8%0.382-6%0.380-5%
Debt To Equity Ratio--0.5650.575-2%0.641-12%0.622-9%0.616-8%
Dividend Per Share--0.0130.016-23%0.024-47%0.022-44%0.018-30%
Eps--0.1490.112+33%0.140+6%0.132+12%0.115+30%
Free Cash Flow Per Share--0.1310.117+12%0.138-5%0.090+46%0.069+90%
Free Cash Flow To Equity Per Share--0.0690.054+28%0.081-16%0.089-23%0.082-17%
Gross Profit Margin--1.0001.0000%1.0000%0.947+6%0.966+4%
Intrinsic Value_10Y_max--10.848--------
Intrinsic Value_10Y_min--9.202--------
Intrinsic Value_1Y_max--0.624--------
Intrinsic Value_1Y_min--0.613--------
Intrinsic Value_3Y_max--2.228--------
Intrinsic Value_3Y_min--2.119--------
Intrinsic Value_5Y_max--4.257--------
Intrinsic Value_5Y_min--3.921--------
Market Cap1475603916.800-39%2048396560.0002150501947.500-5%2726737875.000-25%2885230352.789-29%2671375752.617-23%
Net Profit Margin--0.1890.080+137%0.104+81%0.108+75%0.143+32%
Operating Margin--0.1160.055+110%0.060+92%0.064+79%0.065+78%
Operating Ratio--0.0990.047+110%0.062+60%0.138-29%0.230-57%
Pb Ratio0.821-38%1.1331.228-8%1.618-30%2.199-48%3.140-64%
Pe Ratio4.368-38%6.0319.446-36%8.449-29%11.266-46%12.126-50%
Price Per Share2.600-38%3.5903.760-5%4.738-24%4.972-28%4.633-23%
Price To Free Cash Flow Ratio4.948-38%6.8328.129-16%8.803-22%19.790-65%28.338-76%
Price To Total Gains Ratio17.071-38%23.571203.347-88%135.474-83%121.055-81%91.965-74%
Quick Ratio--1.8431.404+31%1.475+25%1.483+24%1.387+33%
Return On Assets--0.0600.035+73%0.043+38%0.046+30%0.050+20%
Return On Equity--0.0940.054+73%0.071+32%0.075+26%0.081+16%
Total Gains Per Share--0.1520.050+207%0.099+54%0.110+38%0.114+34%
Usd Book Value--231792138.200224788783.730+3%217581475.431+7%181709618.747+28%140569668.129+65%
Usd Book Value Change Per Share--0.0180.004+320%0.010+86%0.011+59%0.012+46%
Usd Book Value Per Share--0.4060.393+3%0.378+7%0.314+29%0.244+67%
Usd Dividend Per Share--0.0020.002-23%0.003-47%0.003-44%0.002-30%
Usd Eps--0.0190.014+33%0.018+6%0.017+12%0.015+30%
Usd Free Cash Flow--9610000.2008608122.841+12%10163866.250-5%6637081.783+45%5102376.452+88%
Usd Free Cash Flow Per Share--0.0170.015+12%0.018-5%0.012+46%0.009+90%
Usd Free Cash Flow To Equity Per Share--0.0090.007+28%0.010-16%0.011-23%0.011-17%
Usd Market Cap189172422.134-39%262604438.992275694349.670-5%349567795.575-25%369886531.228-29%342470371.485-23%
Usd Price Per Share0.333-38%0.4600.482-5%0.607-24%0.637-28%0.594-23%
Usd Profit--21769770.20012306782.228+77%15528853.885+40%13243689.297+64%10706549.468+103%
Usd Revenue--115297823.80050037890.071+130%49873339.282+131%45392909.717+154%39965134.531+188%
Usd Total Gains Per Share--0.0200.006+207%0.013+54%0.014+38%0.015+34%
 EOD+4 -4MRQTTM+27 -8YOY+22 -135Y+27 -910Y+28 -8

3.2. Fundamental Score

Let's check the fundamental score of Essex Bio-Technology Ltd based on Penke's default stock scanner.

Penke's Stock Scanner

  
  
IndicatorConditionValue
Price to Earnings Ratio (EOD)Between0-154.368
Price to Book Ratio (EOD)Between0-10.821
Net Profit Margin (MRQ)Greater than00.189
Operating Margin (MRQ)Greater than00.116
Quick Ratio (MRQ)Greater than11.843
Current Ratio (MRQ)Greater than12.139
Debt to Asset Ratio (MRQ)Less than10.361
Debt to Equity Ratio (MRQ)Less than10.565
Return on Equity (MRQ)Greater than0.150.094
Return on Assets (MRQ)Greater than0.050.060
Total9/10 (90.0%)

3.3. Technical Score

Let's check the technical score of Essex Bio-Technology Ltd based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5066.259
Ma 20Greater thanMa 502.361
Ma 50Greater thanMa 1002.274
Ma 100Greater thanMa 2002.318
OpenGreater thanClose2.580
Total2/5 (40.0%)



Latest Balance Sheet

Balance Sheet of 2023-12-31. Currency in HKD. All numbers in thousands.

Summary
Total Assets2,827,558
Total Liabilities903,781
Total Stockholder Equity1,923,777
 As reported
Total Liabilities 903,781
Total Stockholder Equity+ 1,923,777
Total Assets = 2,827,558

Assets

Total Assets2,827,558
Total Current Assets1,245,278
Long-term Assets1,582,281
Total Current Assets
Cash And Cash Equivalents 509,845
Short-term Investments 5,180
Net Receivables 567,308
Inventory 62,822
Total Current Assets  (as reported)1,245,278
Total Current Assets  (calculated)1,145,155
+/- 100,123
Long-term Assets
Property Plant Equipment 416,476
Goodwill 56,016
Intangible Assets 1,069,426
Long-term Assets  (as reported)1,582,281
Long-term Assets  (calculated)1,541,918
+/- 40,363

Liabilities & Shareholders' Equity

Total Current Liabilities810,744
Long-term Liabilities93,037
Total Stockholder Equity1,923,777
Total Current Liabilities
Short Long Term Debt 235,865
Accounts payable 10,581
Total Current Liabilities  (as reported)810,744
Total Current Liabilities  (calculated)246,446
+/- 564,298
Long-term Liabilities
Long term Debt 36,057
Capital Lease Obligations Min Short Term Debt22,101
Long-term Liabilities  (as reported)93,037
Long-term Liabilities  (calculated)58,157
+/- 34,880
Total Stockholder Equity
Retained Earnings 1,844,992
Total Stockholder Equity (as reported)1,923,777
Total Stockholder Equity (calculated)1,844,992
+/- 78,786
Other
Capital Stock56,759
Common Stock Shares Outstanding 567,585
Net Invested Capital 2,195,699
Net Working Capital 434,534
Property Plant and Equipment Gross 573,450



Balance Sheet

Currency in HKD. All numbers in thousands.

 Trend2023-12-312023-06-302023-03-312022-12-312022-09-302022-06-302022-03-312021-12-312021-09-302021-06-302021-03-312020-12-312020-09-302020-06-302020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-06-302017-12-312017-06-302016-12-312016-06-302015-12-312015-06-302014-12-312014-06-302013-12-312013-06-302012-12-312012-06-302011-12-312011-06-302010-12-312010-06-302009-12-312009-06-302008-12-312008-06-302007-12-312007-06-302006-12-312006-06-302005-12-312005-06-302004-12-312004-06-302003-12-312003-06-302002-12-312002-06-302001-12-31
> Total Assets 
64,935
64,919
73,684
60,206
45,156
47,699
51,356
62,403
75,879
82,901
90,710
125,853
142,125
161,252
185,974
164,842
130,493
138,608
169,191
184,394
217,899
278,694
331,743
372,484
387,012
445,635
503,042
551,922
636,579
823,686
933,297
1,049,187
1,159,777
1,382,056
1,449,689
0
1,642,677
0
2,077,943
0
1,857,843
0
2,421,339
0
2,618,277
0
2,863,439
0
2,794,303
0
2,712,397
0
2,829,122
2,827,558
2,827,5582,829,12202,712,39702,794,30302,863,43902,618,27702,421,33901,857,84302,077,94301,642,67701,449,6891,382,0561,159,7771,049,187933,297823,686636,579551,922503,042445,635387,012372,484331,743278,694217,899184,394169,191138,608130,493164,842185,974161,252142,125125,85390,71082,90175,87962,40351,35647,69945,15660,20673,68464,91964,935
   > Total Current Assets 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
113,397
0
142,144
139,469
153,880
158,681
184,306
175,280
232,166
284,077
329,203
359,466
457,630
555,482
687,525
715,217
867,978
862,598
0
973,645
1,267,491
1,267,491
1,084,610
1,084,610
1,332,855
1,332,855
1,410,069
1,410,069
1,547,391
1,547,391
1,324,600
1,324,600
1,213,978
1,213,978
1,337,241
1,337,241
1,245,278
1,245,2781,337,2411,337,2411,213,9781,213,9781,324,6001,324,6001,547,3911,547,3911,410,0691,410,0691,332,8551,332,8551,084,6101,084,6101,267,4911,267,491973,6450862,598867,978715,217687,525555,482457,630359,466329,203284,077232,166175,280184,306158,681153,880139,469142,1440113,39700000000000000000
       Cash And Cash Equivalents 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
68,411
0
66,055
36,812
52,282
59,831
56,608
54,527
50,320
61,974
74,094
64,613
81,206
156,180
168,923
240,627
308,380
311,098
0
334,730
0
473,341
0
390,388
0
599,782
0
657,754
0
671,336
0
641,136
0
543,486
0
505,722
509,845
509,845505,7220543,4860641,1360671,3360657,7540599,7820390,3880473,3410334,7300311,098308,380240,627168,923156,18081,20664,61374,09461,97450,32054,52756,60859,83152,28236,81266,055068,41100000000000000000
       Short-term Investments 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
7,508
1,064
28
0
26,844
0
10,589
0
1,960
0
15
0
23
0
15
0
11
0
6
0
4,461
5,180
5,1804,4610601101502301501,960010,589026,8440281,0647,50800000000000000000000000000000000
       Net Receivables 
18,870
24,646
31,699
23,583
19,301
9,907
13,583
14,377
15,243
13,578
16,291
30,901
24,063
39,713
36,876
39,060
35,151
40,211
50,764
62,636
77,287
96,633
93,214
121,657
111,408
156,365
161,258
197,386
206,427
259,639
257,758
319,004
319,788
400,035
434,875
0
477,930
651,738
651,738
515,710
515,710
516,169
516,169
575,597
575,597
714,245
714,245
566,456
566,456
500,057
500,057
637,395
637,395
567,308
567,308637,395637,395500,057500,057566,456566,456714,245714,245575,597575,597516,169516,169515,710515,710651,738651,738477,9300434,875400,035319,788319,004257,758259,639206,427197,386161,258156,365111,408121,65793,21496,63377,28762,63650,76440,21135,15139,06036,87639,71324,06330,90116,29113,57815,24314,37713,5839,90719,30123,58331,69924,64618,870
       Other Current Assets 
0
0
0
0
0
0
0
0
0
9,719
0
5,043
155
156
165
315
151
77
1,708
0
162
0
754
0
2,479
0
25,624
0
0
0
35,328
58,327
28,229
1,590
317
0
3,325
4,690
4,690
42,981
42,981
41,218
41,218
50,271
50,271
62,732
62,732
32,368
32,368
77,142
77,142
111,165
111,165
0
0111,165111,16577,14277,14232,36832,36862,73262,73250,27150,27141,21841,21842,98142,9814,6904,6903,32503171,59028,22958,32735,32800025,62402,4790754016201,708771513151651561555,04309,719000000000
   > Long-term Assets 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
669,032
0
810,453
0
773,233
0
1,088,485
0
1,208,208
0
1,316,048
0
1,469,703
0
1,498,419
0
1,491,881
1,582,281
1,582,2811,491,88101,498,41901,469,70301,316,04801,208,20801,088,4850773,2330810,4530669,032000000000000000000000000000000000000
       Property Plant Equipment 
6,278
6,406
8,512
7,959
6,654
5,680
4,127
4,146
11,008
16,531
22,924
22,961
24,119
24,525
24,405
23,228
5,940
5,407
11,437
20,566
35,602
68,438
149,127
161,582
185,687
184,871
182,935
180,101
174,336
169,254
163,902
165,878
177,733
166,392
169,324
184,822
184,822
189,045
189,045
202,319
202,319
279,747
279,747
303,621
303,621
351,903
351,903
385,773
385,773
401,113
401,113
370,444
370,444
416,476
416,476370,444370,444401,113401,113385,773385,773351,903351,903303,621303,621279,747279,747202,319202,319189,045189,045184,822184,822169,324166,392177,733165,878163,902169,254174,336180,101182,935184,871185,687161,582149,12768,43835,60220,56611,4375,4075,94023,22824,40524,52524,11922,96122,92416,53111,0084,1464,1275,6806,6547,9598,5126,4066,278
       Goodwill 
0
0
2,261
0
2,029
0
1,797
1,797
1,953
1,954
2,040
2,109
2,222
2,382
2,383
2,383
2,279
2,300
2,385
2,442
2,489
2,505
2,507
2,571
2,602
2,578
2,589
2,592
2,417
2,352
2,228
2,314
2,435
2,397
2,282
0
16,524
0
21,849
0
22,426
0
24,153
0
24,276
0
50,898
0
84,359
0
57,147
0
54,773
56,016
56,01654,773057,147084,359050,898024,276024,153022,426021,849016,52402,2822,3972,4352,3142,2282,3522,4172,5922,5892,5782,6022,5712,5072,5052,4892,4422,3852,3002,2792,3832,3832,3822,2222,1092,0401,9541,9531,7971,79702,02902,26100
       Long Term Investments 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
83,397
68,895
90,393
148,983
142,132
0
89,356
0
109,774
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
000000000000000109,774089,3560142,132148,98390,39368,89583,397000000000000000000000000000000
       Intangible Assets 
0
6,710
2,261
10,626
2,029
6,656
1,797
1,797
6,172
6,003
4,547
4,474
9,696
10,238
10,151
17,391
10,639
12,591
10,787
16,767
17,015
17,711
17,078
19,095
23,442
26,020
33,441
40,026
41,143
52,925
80,889
95,921
144,624
150,677
235,708
0
328,052
0
393,359
0
428,464
0
602,661
0
660,781
0
792,318
0
938,408
0
978,697
0
998,994
1,069,426
1,069,426998,9940978,6970938,4080792,3180660,7810602,6610428,4640393,3590328,0520235,708150,677144,62495,92180,88952,92541,14340,02633,44126,02023,44219,09517,07817,71117,01516,76710,78712,59110,63917,39110,15110,2389,6964,4744,5476,0036,1721,7971,7976,6562,02910,6262,2616,7100
       Long-term Assets Other 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
669,032
0
810,453
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
000000000000000810,4530669,032000000000000000000000000000000000000
> Total Liabilities 
7,578
6,857
19,526
10,903
11,160
8,409
9,808
9,628
13,236
17,016
22,634
50,354
59,232
55,292
72,200
55,311
22,459
24,398
36,873
40,787
54,638
101,792
135,470
151,962
133,018
166,543
171,996
178,677
223,632
371,157
376,433
431,601
420,288
531,159
520,787
0
591,130
0
880,798
0
686,335
0
995,149
0
1,040,924
0
1,129,162
0
1,051,397
0
981,030
0
1,021,071
903,781
903,7811,021,0710981,03001,051,39701,129,16201,040,9240995,1490686,3350880,7980591,1300520,787531,159420,288431,601376,433371,157223,632178,677171,996166,543133,018151,962135,470101,79254,63840,78736,87324,39822,45955,31172,20055,29259,23250,35422,63417,01613,2369,6289,8088,40911,16010,90319,5266,8577,578
   > Total Current Liabilities 
7,578
6,857
19,237
10,698
11,087
8,385
9,808
9,628
13,236
17,016
22,634
50,354
59,232
55,292
72,200
55,311
21,379
23,318
36,657
40,567
53,558
100,033
131,349
148,182
128,257
163,510
160,479
168,529
208,229
357,532
243,957
294,047
277,153
331,301
315,286
0
345,436
509,090
509,090
518,843
518,843
606,025
606,025
644,094
644,094
689,585
689,585
621,173
621,173
560,917
560,917
625,034
625,034
810,744
810,744625,034625,034560,917560,917621,173621,173689,585689,585644,094644,094606,025606,025518,843518,843509,090509,090345,4360315,286331,301277,153294,047243,957357,532208,229168,529160,479163,510128,257148,182131,349100,03353,55840,56736,65723,31821,37955,31172,20055,29259,23250,35422,63417,01613,2369,6289,8088,38511,08710,69819,2376,8577,578
       Short-term Debt 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
36,887
73,819
69,113
50,768
56,668
50,550
31,621
51,000
158,854
38,780
38,780
29,004
186,601
0
0
16,625
0
19,250
0
210,375
0
200,750
0
0
0
0
0
0
0
0
0
0
0
00000000000200,7500210,375019,250016,62500186,60129,00438,78038,780158,85451,00031,62150,55056,66850,76869,11373,81936,887000000000000000000000
       Short Long Term Debt 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
160,214
165,036
157,978
186,601
0
0
16,625
0
19,250
0
210,375
0
200,750
0
185,929
0
153,366
0
111,346
0
105,045
0
89,888
235,865
235,86589,8880105,0450111,3460153,3660185,9290200,7500210,375019,250016,62500186,601157,978165,036160,214000000000000000000000000000000
       Accounts payable 
2,043
2,187
5,273
3,714
5,997
2,596
1,180
960
253
316
858
22,813
7,270
1,868
4,199
5,169
275
286
210
386
350
356
187
800
435
1,990
1,156
1,628
2,333
1,181
496
1,651
1,266
44,743
3,736
0
11,403
53,140
53,140
5,515
5,515
44,086
44,086
4,289
4,289
4,466
4,466
8,154
8,154
10,657
10,657
8,048
8,048
10,581
10,5818,0488,04810,65710,6578,1548,1544,4664,4664,2894,28944,08644,0865,5155,51553,14053,14011,40303,73644,7431,2661,6514961,1812,3331,6281,1561,9904358001873563503862102862755,1694,1991,8687,27022,8138583162539601,1802,5965,9973,7145,2732,1872,043
       Other Current Liabilities 
5,535
4,670
4,375
6,815
4,993
5,692
8,556
8,645
12,983
9,685
16,796
13,188
23,073
24,476
33,364
21,298
21,104
23,032
36,446
40,181
53,208
62,790
57,343
78,269
77,054
104,852
108,773
135,280
154,896
197,497
204,681
253,616
246,884
63,458
89,927
0
49,042
81,046
81,046
17,260
17,260
74,065
74,065
145,083
145,083
174,398
174,398
121,628
121,628
134,241
134,241
146,865
146,865
0
0146,865146,865134,241134,241121,628121,628174,398174,398145,083145,08374,06574,06517,26017,26081,04681,04649,042089,92763,458246,884253,616204,681197,497154,896135,280108,773104,85277,05478,26957,34362,79053,20840,18136,44623,03221,10421,29833,36424,47623,07313,18816,7969,68512,9838,6458,5565,6924,9936,8154,3754,6705,535
   > Long-term Liabilities 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
245,694
0
371,708
0
167,492
0
389,123
0
396,830
0
439,576
0
430,224
0
420,114
0
396,037
93,037
93,037396,0370420,1140430,2240439,5760396,8300389,1230167,4920371,7080245,694000000000000000000000000000000000000
       Long term Debt Total 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
128,974
186,601
189,366
0
225,547
0
349,878
0
148,997
0
359,765
0
373,782
0
409,270
0
398,626
0
382,121
0
354,968
0
0354,9680382,1210398,6260409,2700373,7820359,7650148,9970349,8780225,5470189,366186,601128,97400000000000000000000000000000000
       Other Liabilities 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
1,969
1,909
0
0
0
0
0
0
11,042
11,298
14,161
13,257
16,135
20,147
20,147
21,830
21,830
18,495
18,495
29,358
29,358
23,048
23,048
30,306
30,306
31,598
31,598
37,992
37,992
41,069
41,069
0
041,06941,06937,99237,99231,59831,59830,30630,30623,04823,04829,35829,35818,49518,49521,83021,83020,14720,14716,13513,25714,16111,29811,0420000001,9091,9690000000000000000000000
       Deferred Long Term Liability 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
54,671
69,537
82,067
91,149
96,201
111,548
111,548
124,664
124,664
134,326
134,326
145,807
145,807
149,653
149,653
188,515
188,515
198,257
198,257
200,560
200,560
216,326
216,326
0
0216,326216,326200,560200,560198,257198,257188,515188,515149,653149,653145,807145,807134,326134,326124,664124,664111,548111,54896,20191,14982,06769,53754,671000000000000000000000000000000
> Total Stockholder Equity
51,852
55,472
52,297
47,996
33,941
39,290
41,548
52,775
57,439
60,285
63,496
70,816
77,502
95,472
102,898
102,047
108,034
114,210
132,318
143,607
163,261
176,902
196,273
220,522
253,994
279,092
331,046
373,245
412,947
452,529
556,864
617,586
739,488
850,897
928,902
0
1,051,547
0
1,197,145
0
1,171,508
0
1,426,191
0
1,577,353
0
1,734,277
0
1,742,906
0
1,731,367
0
1,808,051
1,923,777
1,923,7771,808,05101,731,36701,742,90601,734,27701,577,35301,426,19101,171,50801,197,14501,051,5470928,902850,897739,488617,586556,864452,529412,947373,245331,046279,092253,994220,522196,273176,902163,261143,607132,318114,210108,034102,047102,89895,47277,50270,81663,49660,28557,43952,77541,54839,29033,94147,99652,29755,47251,852
   Common Stock
51,282
54,682
55,524
55,524
55,524
55,524
55,524
55,524
55,524
55,665
55,675
55,675
55,675
55,675
55,675
55,675
55,675
55,675
55,675
55,675
55,675
55,675
55,675
55,675
55,675
55,675
55,675
55,675
55,954
55,954
56,215
56,215
56,349
57,101
57,875
57,881
57,881
57,794
57,794
57,794
57,794
57,690
57,690
57,672
57,672
57,556
57,556
57,417
57,417
57,160
57,160
57,058
57,058
0
057,05857,05857,16057,16057,41757,41757,55657,55657,67257,67257,69057,69057,79457,79457,79457,79457,88157,88157,87557,10156,34956,21556,21555,95455,95455,67555,67555,67555,67555,67555,67555,67555,67555,67555,67555,67555,67555,67555,67555,67555,67555,67555,67555,66555,52455,52455,52455,52455,52455,52455,52454,68251,282
   Retained Earnings Total Equity000000000000000000000000000000000000000000000000000000
   Accumulated Other Comprehensive Income 00000000000-98,5550-82,9490-76,1700-67,4090-59,289-54,817-48,373-39,735-32,782-28,562-23,870-20,220-15,279-10,387-10,125-8,918-8,365-15,960-15,460-14,8290000000000000000000
   Capital Surplus 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
21,858
45,932
70,720
0
71,110
0
71,108
0
71,108
0
71,106
0
73,295
0
73,293
0
73,290
0
73,286
0
73,284
0
073,284073,286073,290073,293073,295071,106071,108071,108071,110070,72045,93221,85800000000000000000000000000000000
   Treasury Stock000000000000000000000000000000000000000000000000000000
   Other Stockholders Equity 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
29,583
31,173
54,956
61,932
2,885
3,237
-2,022
-8,331
-8,331
-55,871
-55,871
31,490
31,490
49,357
49,357
49,174
49,174
-43,941
-43,941
-109,832
-109,832
-186,779
-186,779
0
0-186,779-186,779-109,832-109,832-43,941-43,94149,17449,17449,35749,35731,49031,490-55,871-55,871-8,331-8,331-2,0223,2372,88561,93254,95631,17329,583000000000000000000000000000000



Balance Sheet

Currency in HKD. All numbers in thousands.




Cash Flow

Currency in HKD. All numbers in thousands.




Income Statement

Currency in HKD. All numbers in thousands.


Latest Income Statement (annual, 2023-12-31)

Gross Profit (+$)
totalRevenue1,706,556
Cost of Revenue-167,263
Gross Profit1,539,2931,539,293
 
Operating Income (+$)
Gross Profit1,539,293
Operating Expense-1,394,875
Operating Income311,681144,418
 
Operating Expense (+$)
Research Development0
Selling General Administrative1,228,963
Selling And Marketing Expenses0
Operating Expense1,394,8751,228,963
 
Net Interest Income (+$)
Interest Income12,343
Interest Expense-11,212
Other Finance Cost-0
Net Interest Income1,131
 
Pretax Income (+$)
Operating Income311,681
Net Interest Income1,131
Other Non-Operating Income Expenses0
Income Before Tax (EBT)346,014311,681
EBIT - interestExpense = -11,212
275,260
286,472
Interest Expense11,212
Earnings Before Interest and Taxes (EBIT)0357,227
Earnings Before Interest and Taxes (EBITDA)0
 
After tax Income (+$)
Income Before Tax346,014
Tax Provision-70,755
Net Income From Continuing Ops275,260275,260
Net Income275,260
Net Income Applicable To Common Shares0
 
Non-recurring Events
Discontinued Operations0
Extraordinary Items0
Effect of Accounting Charges0
Other Items0
Non Recurring0
Other Operating Expenses0
Total Other Income/Expenses Net0-1,131
 

Technical Analysis of Essex Bio-Technology Ltd
The psychology behind the price

Technical indicators reflecting market sentiment and the collective psychology of you and other traders. Your emotions and other traders' emotions, such as fear and greed, play a significant role in driving price movements.

General trend

First of all, I'm going to put something in the back of your mind. One of the most stable factors that gives you more confidence as a trader: the general trend of Essex Bio-Technology Ltd. The general trend of Essex Bio-Technology Ltd is BULLISH with 28.6% confidence. It is very important for your mental being to use each indicator with this in mind. But beware, also the general trend flips once in a while! You can use moving averages to determine Essex Bio-Technology Ltd's overall trend. For convenience I use the most commonly used moving averages: 20, 50, 100 & 200. Of course you can use other moving averages or other indicators to determine the trend.

Indicator phases

Some of the indicators I use have 3 zones: overbought, oversold and neutral. Transitions between these zones (market phases) provide valuable trading signals and insights. Expecially with the general trend mind, I use the highlighted phases:

Indicator zone transitionsBullish trend (28.6%) Bearish trend (-28.6%)
Overbought to neutralBullish pullback=Bearish reversal
Upper to lower neutralBullish correction=Bearish continuation
Nuetral to oversoldOversold=Oversold
Oversold to neutralBullish reversal=Bearish correction
Lower to upper neutralBullish continuation=Bearish pullback
Nuetral to overboughtOverbought=Overbought

1. Price Targets

1.1 Support & Resistance

Support and resistance are levels on a price chart that act as barriers or zones where the price of an asset tends to stop, reverse, or experience a significant amount of buying or selling pressure.

Support is a price level at which demand for an asset is strong enough to prevent the price from falling further.
Resistance is a price level at which selling pressure becomes significant enough to prevent the price of an asset from rising further.


Score

Let's take a look at the Support & Resistance of Essex Bio-Technology Ltd.

The long score for the Support & Resistance is 0/1.
The longshort score for the Support & Resistance is 0/(-1 +1).

  • Between support/resistance: The price is trading between support and resistance lines.

The bullish price targets are: 2.65 < 2.65 < 2.69.

The bearish price targets are: 2.32 > 2.17 > 2.14.

Tweet this
Essex Bio-Technology Ltd Daily Support & Resistance Chart

2. Trend Indicators

2.1 Moving Averages

Shows the moving average of the selected period.

  • Moving averages are lagging trend indicators.
  • There are many types of moving averages.
  • Moving averages are also used within other indicators.

Score

Let's take a look at the Moving Averages of Essex Bio-Technology Ltd. The current mas is .

The long score for the Moving Averages is 9/14.
The longshort score for the Moving Averages is 4/(-14 +14).

  • MA 20 trending up: The MA 20 is trending up. +1
  • Close > MA 20: The price is above the MA 20. +1
  • MA 20 > MA 50: The MA 20 is higher than the MA 50. +1
  • MA 20 > MA 100: The MA 20 is higher than the MA 100. +1
  • MA 20 < MA 200: The MA 20 is lower than the MA 200. -1
  • MA 50 trending up: The MA 50 is trending up. +1
  • Close > MA 50: The price is above the MA 50. +1
  • MA 50 < MA 100: The MA 50 is lower than the MA 100. -1
  • MA 50 < MA 200: The MA 50 is lower than the MA 200. -1
  • MA 100 trending up: The MA 100 is trending up. +1
  • Close > MA 100: The price is above the MA 100. +1
  • MA 100 < MA 200: The MA 100 is lower than the MA 200. -1
  • MA 200 trending down: The MA 200 is trending down. -1
  • Close > MA 200: The price is above the MA 200. +1

Directionalities and relatives.

Moving AverageAmount of candlesTrendPrice +/-vs. MA 50vs. MA 100vs. MA 200
MA 2020
MA 5050-
MA 100100--
MA 200200---

Explanation: https://www.youtube.com/watch?v=xwW8h0lrQ-I

Essex Bio-Technology Ltd Daily Moving Averages Chart
2.2 Moving Average Convergence/Divergence (MACD)

Shows the momentum of the selected period based on two moving averages.

  • MACD is a lagging momentum indicator.
  • Uses two moving averages.
  • Can show buy or sell signals based on momentum.
  • Can show overbought. and oversold. levels.

Score

Let's take a look at the Moving Average Convergence/Divergence (MACD) of Essex Bio-Technology Ltd. The current macd is 0.07324807.

The long score for the Moving Average Convergence/Divergence (MACD) is 4/4.
The longshort score for the Moving Average Convergence/Divergence (MACD) is 4/(-4 +4).

  • MACD line > signal line: The MACD line is above the signal line, which indicates a bullish signal in the market. This means that the positive momentum is currently stronger than the average momentum, suggesting that buyers are more active than sellers, and there's a higher probability of the Essex Bio-Technology Ltd price going up in the near term. +2
  • MACD > 0: The MACD is above the zero line (centerline), it indicates a bullish signal for Essex Bio-Technology Ltd. This means that the short-term moving average is higher than the long-term moving average, signaling positive momentum and suggesting a higher likelihood of the Essex Bio-Technology Ltd price continuing to rise in the near future. It indicates that buyers are gaining control, and there is optimism in the market, leading to potential price increases. +1
  • Trending up: The MACD line is trending up. This indicates that the short-term moving average is rising faster than the long-term moving average, suggesting positive momentum in the market. This signals that buyers are becoming more active and confident, leading to potential price increases as traders anticipate further gains and are willing to buy at higher prices. +1
Essex Bio-Technology Ltd Daily Moving Average Convergence/Divergence (MACD) ChartEssex Bio-Technology Ltd Daily Moving Average Convergence/Divergence (MACD) Chart
2.3 Directional Movement Index (DMI)

The DMI is a collection of 3 indicators: +DI (Plus Direction Indicator), -DI (Minus Direction Indicator) and ADX (Average Directional Index). The ADX helps you determine the strength of a trend.


Score

Let's take a look at the Directional Movement Index (DMI) of Essex Bio-Technology Ltd. The current adx is 25.34.

The long score for the Directional Movement Index (DMI) is 4/7.
The longshort score for the Directional Movement Index (DMI) is 4/(-7 +7).

  • PLUS_ID > MINUS_DI: The +DI line is above the -DI line. This indicates a bullish signal in the market, as the positive directional movement is currently stronger than the negative directional movement, showing that buyers have the upper hand. Market psychology suggests that traders are optimistic, expecting further price increases, and are more willing to buy Essex Bio-Technology Ltd shares, leading to potential upward momentum in its price. +1
  • PLUS_ID > MINUS_DI && ADX > 25 && ADX trending up: The ADX is above 25 and indicates a strong bullish trend. The ADX is trending up, so the bullish trend is strengthening.
Essex Bio-Technology Ltd Daily Directional Movement Index (DMI) Chart
2.4 Parabolic SAR

Shows the current trend and potential entry and exit signals.

  • Parabolic SAR (stop and reverse) is a lagging trend indicator.
  • Shows the current trend.
  • Shows potential entry signals.
  • Shows  potential exit signals.
  • Can be used to place trailing stoplosses..

Score

Let's take a look at the Parabolic SAR of Essex Bio-Technology Ltd. The current sar is 2.36269886.

The long score for the Parabolic SAR is 1/1.
The longshort score for the Parabolic SAR is 1/(-1 +1).

  • Close > SAR: The price is above the SAR. It's generally considered a bullish signal. +1
Essex Bio-Technology Ltd Daily Parabolic SAR Chart

3. Momentum Indicators

3.1 Relative Strength Index (RSI)

Measures the speed and change of price movements.

  • Leading momentum indicator, meaning the signals are instant.
  • Ranges between 0 and 100.
  • Above 70 is considered overbought.
  • Below 30 is considered oversold.
  • Above or below 50 can also be used to determine price trend or support and resistance.
  • RSI divergence looks at a deviation between RSI and price movement. Penketrading automatically calculates RSI divergences.
  • Can be used in many different ways

Score

Let's take a look at the Relative Strength Index (RSI) of Essex Bio-Technology Ltd. The current rsi is 66.26. The current phase is Continuation in bull market.

The long score for the Relative Strength Index (RSI) is 4/13.
The longshort score for the Relative Strength Index (RSI) is 4/(-13 +13).

  • Continuation in bull market: Uptrend continues after a consolidation or pullback. Hold or add to existing positions.
  • Trending up: The RSI is trending up. +1
Essex Bio-Technology Ltd Daily Relative Strength Index (RSI) ChartEssex Bio-Technology Ltd Daily Relative Strength Index (RSI) Chart
3.2 Stochastic Oscillator

Compares a certain price to multiple prices ranging over time.

  • Leading momentum indicator, meaning the signals are instant.
  • Used to determine overbought and oversold areas much like the RSI.
  • Ranges between 0 and 100.
  • Above 80 is considered overbought.
  • Below 20 is considered oversold.
  • Consists of two lines named K and D.
  • K compares the highest high and lowest low on the selected price range.
  • The D line is a moving average of the K line.
  • Can be used to spot divergences

Score

Let's take a look at the Stochastic Oscillator of Essex Bio-Technology Ltd. The current phase is Overbought in bull market.

The long score for the Stochastic Oscillator is 6/6.
The longshort score for the Stochastic Oscillator is 6/(-6 +6).

  • STOCH > 50: The STOCH %K is above 50. There are more buyers than sellers. +1
  • STOCH > 80: The STOCH %K is above 80 and overbought. +2
  • STOCH %K line > STOCH %D line: The STOCH %K line is above the STOCH %D line, which indicates a bullish signal in the market. This means that the positive momentum is currently stronger than the average momentum, suggesting that buyers are more active than sellers, and there's a higher probability of the Essex Bio-Technology Ltd price going up in the near term. +2
  • Trending up: The STOCH %K is trending up. +1
Essex Bio-Technology Ltd Daily Stochastic Oscillator ChartEssex Bio-Technology Ltd Daily Stochastic Oscillator Chart
3.3 Commodity Channel Index (CCI)

Measures the difference between the current price and the historical average price.

  • Lagging or leading Momentum indicator
  • When the CCI is above zero, the price is above the historical average
  • When the CCI is below zero, the price is below the historical average
  • Used for spotting trends
    • If the CCI moves from negative or near zero to positive 100 that might indicate an uptrend
    • If the CCI moves from positive or near zero to negative -100 that might indicate a downtrend

Score

Let's take a look at the Commodity Channel Index (CCI) of Essex Bio-Technology Ltd. The current cci is 130.00.

The long score for the Commodity Channel Index (CCI) is 1/1.
The longshort score for the Commodity Channel Index (CCI) is 1/(-1 +1).

  • CCI > 100: The CCI is above 100, it indicates that the price is significantly above its average, suggesting a potential overbought condition. +1
Essex Bio-Technology Ltd Daily Commodity Channel Index (CCI) ChartEssex Bio-Technology Ltd Daily Commodity Channel Index (CCI) Chart
3.4 Chande Momentum Oscillator (CMO)

Measures the difference between the sum of recent gains and the sum of recent losses. Then divides the result by the sum of all price movements in that period.

  • Lagging momentum indicator
  • Ranges between +100 and -100
  • Considered overbought above +50
  • Considered oversold below -50
  • It's possible to add a moving average that acts as a signal line

Score

Let's take a look at the Chande Momentum Oscillator (CMO) of Essex Bio-Technology Ltd. The current cmo is 37.85.

The long score for the Chande Momentum Oscillator (CMO) is 1/1.
The longshort score for the Chande Momentum Oscillator (CMO) is 1/(-1 +1).

  • CMO > 0: The CMO is above 0, the momentum of the price is positive, indicating a potential uptrend in the price. +1
Essex Bio-Technology Ltd Daily Chande Momentum Oscillator (CMO) ChartEssex Bio-Technology Ltd Daily Chande Momentum Oscillator (CMO) Chart
3.5 Williams %R

 Shows the current price relative to the highest high over the last 14 days.
 

  • Lagging momentum indicator
  • Ranging between 0 and -100
  • Above -20 is considered overbought
  • Below -80 is considered oversold
  • Is prone to give false signals

Score

Let's take a look at the Williams %R of Essex Bio-Technology Ltd. The current willr is -19.23076923.

The long score for the Williams %R is 1/1.
The longshort score for the Williams %R is 1/(-1 +1).

  • WILLR > -20: The Williams %R is above -20. This indicates that the price is in overbought territory, suggesting a potential price correction or trend reversal to the downside. +1
Essex Bio-Technology Ltd Daily Williams %R ChartEssex Bio-Technology Ltd Daily Williams %R Chart

4. Volatility Indicators

4.1 Bollinger Bands

Shows if the price is to high or to low relative to an average.

  • Lagging volatility indicator
  • Uses 3 bands: one upper, one lower and one in the middle
  • Works best when the middle band reflects an intermediate trend (MA20).
  • When the price is moving closer to the upper band, the market might be overbought
  • When the price is moving closer to the lower band, the market might be oversold 

Score

Let's take a look at the Bollinger Bands of Essex Bio-Technology Ltd.

Essex Bio-Technology Ltd Daily Bollinger Bands Chart
4.2 Average True Range (ATR)
Measures market volatility
  • Leading volatility indicator
  • Can be used to determine stop-loss positions
  • Calculated by:
    • Current high minus the current low
    • Current high minus the previous close
    • Current low minus the previous close
  • The larger the range of the candles, the greater the ATR value

Score

Let's take a look at the Average True Range (ATR) of Essex Bio-Technology Ltd. The current atr is 0.09438875.

Essex Bio-Technology Ltd Daily Average True Range (ATR) ChartEssex Bio-Technology Ltd Daily Average True Range (ATR) Chart

5. Volume Indicators

5.1 On-Balance Volume (OBV)

 Measures market volatility

  • Leading momentum indicator
  • Calculation:
    • If the closing price is above the previous closing price: OBV = previous OBV + current volume
    • If the closing price is below the previous closing price: OBV = previous OBV - current volume
    • If the closing price is the same as the previous closing price than the OBV is the same.
  • Can be used to confirm price trends
  • Can be used with divergences

Score

Let's take a look at the On-Balance Volume (OBV) of Essex Bio-Technology Ltd. The current obv is -6,644,746.

Essex Bio-Technology Ltd Daily On-Balance Volume (OBV) ChartEssex Bio-Technology Ltd Daily On-Balance Volume (OBV) Chart
5.2 Money Flow Index (MFI)

Measures the flow of money in and out of a security

  • Lagging momentum indicator
  • Looks like RSI but uses volume as an extra metric (RSI only considers price)
  • Above 80 is considered overbought
  • Below 20 is considered oversold
  • Can be used with divergences

Score

Let's take a look at the Money Flow Index (MFI) of Essex Bio-Technology Ltd. The current mfi is 81.30.

The long score for the Money Flow Index (MFI) is 2/2.
The longshort score for the Money Flow Index (MFI) is 2/(-2 +2).

  • MFI > 50: +1
  • MFI > 80: +1
Essex Bio-Technology Ltd Daily Money Flow Index (MFI) ChartEssex Bio-Technology Ltd Daily Money Flow Index (MFI) Chart

6. Summary

6.1. Notifications

TypeNotificationDate
PenkeCurrently no notifications for Essex Bio-Technology Ltd.

6.2. Trading Signals

Below you will find trading signals as the indicator is commonly used. This doesn't mean you should use it that way. Learn from these, but don't use them blindly. I recommend using at least 4 indicators, 1 from each category: trend, momentum, volatility and volume.

DateIndicatorSignal
2023-12-19DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
RSI LONG ENTRY SHORT CLOSE30 crossover to upside
2023-12-20MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2023-12-21CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2023-12-27SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
MFI LONG ENTRY SHORT CLOSE20 crossover to upside
2023-12-28ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2023-12-29STOCH LONG EXITThe %K line crosses below the %D line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
2024-01-04STOCH SHORT EXITThe %K line crosses above the %D line.
2024-01-08STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-01-10STOCH SHORT EXITThe %K line crosses above the %D line.
2024-01-11CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-01-12CCI LONG ENTRY SHORT CLOSE100 crossover to upside
2024-01-15STOCH LONG EXITThe %K line crosses below the %D line.
2024-01-16DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-01-17SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-01-18MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
STOCH SHORT EXITThe %K line crosses above the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2024-01-23STOCH LONG EXITThe %K line crosses below the %D line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-01-24STOCH SHORT EXITThe %K line crosses above the %D line.
2024-01-29STOCH LONG EXITThe %K line crosses below the %D line.
2024-01-30MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
STOCH SHORT EXITThe %K line crosses above the %D line.
2024-01-31DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-02-01DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
STOCH LONG EXITThe %K line crosses below the %D line.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-02-06CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-02-08STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-02-14STOCH LONG EXITThe %K line crosses below the %D line.
2024-02-16MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2024-02-19MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-02-21STOCH SHORT EXITThe %K line crosses above the %D line.
MFI LONG ENTRY SHORT CLOSE20 crossover to upside
2024-02-23STOCH LONG EXITThe %K line crosses below the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2024-02-26STOCH SHORT EXITThe %K line crosses above the %D line.
2024-02-27STOCH LONG EXITThe %K line crosses below the %D line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-02-29STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
MFI LONG ENTRY SHORT CLOSE20 crossover to upside
2024-03-01STOCH LONG EXITThe %K line crosses below the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-03-05BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-03-06MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2024-03-11RSI LONG ENTRY SHORT CLOSE30 crossover to upside
MFI LONG ENTRY SHORT CLOSE20 crossover to upside
2024-03-14CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-03-15MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-03-19DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-03-20CCI LONG ENTRY SHORT CLOSE100 crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-03-21STOCH LONG EXITThe %K line crosses below the %D line.
2024-03-28MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2024-04-02DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
MFI SHORT ENTRY LONG CLOSE80 crossover to downside
2024-04-08STOCH SHORT EXITThe %K line crosses above the %D line.
2024-04-09MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
STOCH LONG EXITThe %K line crosses below the %D line.
2024-04-11WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-04-15STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2024-04-16MFI LONG ENTRY SHORT CLOSE20 crossover to upside
2024-04-18MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
2024-04-19WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-04-23STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-04-24MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-04-25MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2024-04-26STOCH SHORT EXITThe %K line crosses above the %D line.
2024-04-29MFI LONG ENTRY SHORT CLOSE20 crossover to upside
2024-04-30CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-05-02MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-05-06STOCH LONG EXITThe %K line crosses below the %D line.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-05-07MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2024-05-08MFI SHORT ENTRY LONG CLOSE80 crossover to downside
2024-05-09ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-05-13STOCH SHORT EXITThe %K line crosses above the %D line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-05-14STOCH LONG EXITThe %K line crosses below the %D line.
2024-05-16STOCH SHORT EXITThe %K line crosses above the %D line.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
MFI LONG ENTRY SHORT CLOSE80 crossover to upside

6.3. Candlestick Patterns

Essex Bio-Technology Ltd Daily Candlestick Chart
DateCandlestick Pattern

6.4. Technical Score

Let's check the technical score of Essex Bio-Technology Ltd based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5066.259
Ma 20Greater thanMa 502.361
Ma 50Greater thanMa 1002.274
Ma 100Greater thanMa 2002.318
OpenGreater thanClose2.580
Total2/5 (40.0%)
Penke

Good job! You gained 25 XP and 0   0   10 . What's next:

  • Share my analysis of Essex Bio-Technology Ltd with someone you think should read this too:
  • Are you bullish or bearish on Essex Bio-Technology Ltd? Let me know what you think in the comments.
  • Do you want an email if I find something interesting about Essex Bio-Technology Ltd? Add an email alert using the form below.
  • Join the community if you want to keep your earnings and track your progress: Join the community
  • Is this analysis useful to you? Support me via But Me a Coffee. I'll analyze the stock market faster for you!

Get notifications about Essex Bio-Technology Ltd

I send you an email if I find something interesting about Essex Bio-Technology Ltd.


Comments

How you think about this?

Leave a comment

Stay informed about Essex Bio-Technology Ltd.

Receive notifications about Essex Bio-Technology Ltd in your mailbox!